Researchers at Thomas Jefferson University have found a new way to help. Their study showed that using two diabetes ...

This discovery shows that a thoughtful combination of medicines can make a big difference in treating complex cases of Type 2 ...

Objective–To investigate the effect of treatment with the glucagon-like peptide 1 receptor agonist exenatide on weight loss and metabolic parameters in obese nondiabetic women. Research Design ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

Trulicity, or dulaglutide, increased from $5.6 billion to $17.6 billion, while the combined spending on liraglutide and exenatide products, like Victoza, Bydureon and Byetta, actually decreased by $4 ...

Data Sources: PubMed was searched (to December 5, 2011) using the terms exenatide, liraglutide, albiglutide, and lixisenatide. The search was limited to studies published in English and conducted ...

Two-year data from a phase 3 trial of exenatide in Parkinson’s is due later this year and could help answer that question, said Prof Foltynie.

The FDA approved the first generic in this class of medications last month after clearing a copycat version of Amylin's weekly injectable GLP-1 Byetta (exenatide) from Amneal Pharma. The regulator ...

A new data-sparse model that can predict a person’s glycaemic response without taking blood or stool samples has been developed. Researchers from the Stevens Institute of Technology in the US have ...

The acronym GLP-1 has become an increasingly popular term in the health arena, especially in the context of weight loss.

A mediterranean diet and regular exercise can combat age-related bone mineral density loss in older women with metabolic syndrome, new evidence has demonstrated. Researchers have found that a ...